Whilst the aetiology of the majority of CIMP remains unexplained in CRC, the pattern of methylation and gene expression suggest that the mechanism(s) may be shared with IDH, potentially allowing the identification of additional candidate CIMP driver genes in CRC and other cancer types. This evidence concerns the gene IDH2 and cancer.